StonvexLoading…
StonvexStonvexStonvexCore line items from JBLU's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $9.06B | $9.28B | $9.62B | $9.16B |
Operating Income | $-368.00M | $-684.00M | $-230.00M | $-298.00M |
Net Income | $-602.00M | $-795.00M | $-310.00M | $-362.00M |
EPS (Diluted) | $-1.66 | $-2.30 | $-0.93 | $-1.12 |
Total Assets | $16.57B | $16.84B | $13.85B | $13.04B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.95B | $1.92B | $1.17B | $1.04B |
Free Cash Flow OCF − CapEx | $-1.17B | $-1.33B | $-728.00M | $-388.00M |
Shares Outstanding | 370.00M | 353.00M | 339.00M | 327.00M |